   |
Max J. Coppes, Russell E. Ware, Jeffrey S. Dome
This issue highlights some of the exciting new developments in pediatric
oncology and hematology. Three articles are devoted to pediatric leukemia,
which remains the most common form of pediatric cancer. Specifically, articles
address ALL, AML, and leukemia in patients with Down syndrome. Other articles
that address pediatric oncology include CNS tumors and neuroblastoma as well as
advances in cancer immunotherapy. A very interesting article addresses the
challenges experienced by adults who survived a childhood cancer. The hematology
articles in this issue cover aspects that most clinicians see on a regular
basis-sickle cell disease, thalassemia, and hemophilia, and ITP. |
